Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohnʼs Disease

Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12

(2013) Jan Däbritz et al.   INFLAMMATORY BOWEL DISEASES

Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases

(2013) Stephane Nancey et al.   INFLAMMATORY BOWEL DISEASES

Serum calprotectin as a biomarker for Crohn's disease

(2013) M.-A. Meuwis et al.   Journal of Crohns & Colitis

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

(2012) Pauliina Molander et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

S100A12 in EDTA plasma – A cautionary tale

(2012) B. Meijer et al.   Journal of Crohns & Colitis

Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study

(2011) D. Laharie et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease

(2011) Anastassios C. Manolakis et al.   DIGESTIVE DISEASES AND SCIENCES

Update of fecal markers of inflammation in inflammatory bowel disease

(2011) Thomas A Judd et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

(2007) Marc A. Sidler et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES